Pattern of lateral neck metastases in N0 papillary thyroid carcinoma by Patron, Vincent et al.
RESEARCH ARTICLE Open Access









Background: Indication and extent of lateral prophylactic neck dissection (PLND) in papillary thyroid carcinoma
(PTC) is very controversial.
Methods: We retrospectively analysed 131 patients who underwent thyroidectomy and prophylactic lateral neck
dissection from level II to V for PTC.
Results: 140 PLND were performed. The occult lymph node metastases (OLNM) overall rate was 18.6%. The
incidence of node involvement was 10% at level III and 6.4% at level IIa. Level IV and level Vb were both
concerned by 5.7% OLNM. Only 2.9% of level IIb contained OLNM. None of the level Va ND revealed OLNM.
Conclusions: OLNM from PTC occurs commonly in level IIa, III, IV and Vb. Incidence in other levels is low. For
surgeons that usually perform PLND, we believe that a selective neck dissection of levels IIa, III, IV and Vb in N0
neck PTC is sufficient for the clearance of occult metastases.
Background
The management of papillary thyroid carcinoma (PTC)
with no clinical nodes remains controversial. Occult
lymph node metastases (OLNM) occur in 21 to 90% of
patients [1-3], but their role as a prognostic factor for
recurrence or death has not been clearly established.
There has been recent consensus that in N0 microcarci-
nomas the best management may be that of a wait-and-
see policy. However, the place for central and lateral
neck dissection for tumours of more than 1cm in dia-
meter, without clinical lymph node involvement remains
controversial.
Extensive radical neck dissection and modified radical
neck dissection (ND) leads to an increase in morbidity,
mainly due to spinal accessory nerve (SAN) injury
which may result in shoulder pain and dysfunction.
Moreover, the use of radioactive iodine has allowed suc-
cessful non-operative management of low-volume cervi-
cal disease [4,5]. Thus, many surgeons do not
systematically perform prophylactic lateral neck
dissection (PLND), while others routinely proceed to
modified radical neck dissection (MRND) [6].
Decisions regarding the extent of lymphadenectomy
required for N0 PTC should be based on predictable
drainage patterns. A better understanding of node distri-
bution could be critical to achieving more selective neck
dissection. This field has been little investigated in PTC
compared to other head and neck carcinomas and a
recent approach involving sentinel biopsy has not yet
answered to this question [7].
To study the incidence, extent and spread of lateral
node metastasis in PTC we retrospectively reviewed
data from patients in our institution treated with sys-
tematic prophylactic neck dissection.
Methods
Medical records of 631 patients who underwent a sur-
gery for thyroid carcinoma in our institution from
January 1974 to December 2006 were reviewed. Patients
included had criteria of a histological diagnosis of papil-
lary thyroid carcinoma in previously untreated tumours
of greater than 10mm with no evidence of node involve-
ment on clinical examination and US imaging. Dissec-
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reports was conducted to ascertain the prevalence and
distribution of cervical metastases according to neck
level. Data from 16 ND were excluded because of miss-
ing histological or surgical reporting, leaving 140 PLND
in 131 patients to be analyzed.
Total thyroidectomy was the standard procedure. Ipsi-
lateral MRND including levels II, III, IV and V with or
without level I was performed if the lesion was located
in only one lobe. A bilateral MRND was performed if
the lesion was located in the isthmus or disease was pre-
sent in both lobes. All fascial and nodal tissues con-
tained in level II to V were routinely removed. Those of
level Ib were dissected depending upon the surgeon’s
choice at the time. The spinal accessory nerve (SAN),
the internal jugular vein and the sternocleidomastoid
muscle were systematically preserved. All patients
underwent a systematic level VI (central compartment)
per-operative exploration. In cases with suspicious cen-
tral node involvement, a full dissection to level VI was
performed: all fat and fascia between the trachea and
the common carotid artery were removed after identifi-
cation of the inferior laryngeal nerve (paratracheal ND).
Additional pretracheal and pericricoid ND were also
performed. All neck levels were marked and sent for
pathological analysis with conventional haematoxylin-
eosin staining. No immunochemistry was performed.
Lymph nodes levels were retrospectively defined using
the agreed nomenclature of the AAO-HNS [8].
Results
Of the 131 selected patients, 102 were women (78%)
and 29 were men (22%) with a mean age of 38.3 years
[range 12-67 years]. Total thyroidectomy was performed
in 126 patients (96%) and lobectomy in five patients
(4%). Tumour size is resumed in table 1.
Of the 140 PLND performed in these 131 patients,
nine patients required bilateral dissection. Lateral neck
dissection was associated with a level VI full dissection
in 37 cases (26%). 98 of the 140 PLND (70%) included a
level Ib dissection. A mean of 13.5 lymph nodes per
PLND [range 3-44 lymph nodes] was analyzed (1574
lymph nodes in 117 PLND).
The rate of positive findings in lateral neck dissection
was 18.6% (26 of the 140 PLND). The average number
of invaded nodes was 2.6 [range 1-8 OLNM] per posi-
tive neck (68 OLNM in 26 PLND).
The distribution of OLNM is reported in table 2. The
highest incidence of OLNM in the lateral compartment
was found in level III dissections, with 14 neck speci-
mens (10%) demonstrating OLNM (Figure 1). Nine spe-
cimens revealed OLNM at level IIa (6.4%), eight at level
IV (5.7%) and eight at level Vb (5.7%). Of the 98 levels
Ib dissections, three contained OLNM (3.1%). Only four
(2.9%) level IIb dissections contained OLNM. None of
the level Va specimens revealed any OLNM.
In 14 neck specimens (53%) OLNM only occurred at
o n el e v e l :I b( n=2 ) ,I I a( n=2 ) ,I I I( n=4 ) ,I V( n=2 )
a n dV b( n=4 ) ,w h e r e a sn ol e v e lI I bh a da n yi s o l a t e d
metastases. In 12 neck dissections (47%), OLNM were
found at multiple levels. Level IIb metastases were asso-
ciated with metastases with level IIa in 1 case, level III
in 2 cases and with level IV and Vb disease in 1 case.
Level IIa metastases, in multilevel involvement, were
always associated with level III metastases (7 of 7 speci-
mens). Most of the multilevel involvements including
level Vb OLNM (3 of 4 specimens) had level IV OLNM.
Level Ib was associated with level III and IV involve-
ment in only one case.
Table 1 Patient demographics
Characteristics No. Patients (%)




Average age (range) 38.3 y (12-67 y)
Tumor size
10mm ≤ T ≤ 20mm 87 (66)

















IIb + III 2
IIa + III + IV 2
IV + Vb 1
Ib + III + IV 1
IIa + III + Vb 1
IIb + IV + Vb 1
IIa + IIb + III + IV + Vb 1
Total 26
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prehensive neck dissection of lateral and central com-
partments, revealed OLNM in both central and lateral
compartments in five ND (13.5%), in central compart-
ment alone in four ND (10.8%) and in lateral compart-
ment alone in 3 (8.1%).
Discussion
There is ongoing debate about the appropriate manage-
ment of neck metastases in PTC. It is agreed that a
‘wait-and-see policy’ is adequate in N0 microcarcinomas
and that therapeutic ND is always indicated in clinically
positive lymph node metastasis. The current practice is
for systematic central lymphadenectomy as reports sug-
gest that this could reduce lymph node recurrence rates
[9], but recent recommendations stated that prophylac-
tic central node dissection may be not necessary for non
invasive T1, T2 PTC [10]. Also, the management of N0
lateral disease remains controversial.
There is debate regarding which patients would bene-
fit from neck dissection as well as the extent of the neck
dissection [11]. Predictive factors may help better select
patients who may be suitable for a ‘wait-and-see policy’
rather than neck dissection [11], but there is little data
concerning those with N0 disease [12]. Moreover, data
regarding the prognostic significance of OLNM are con-
tradictory [12,13]. When the decision of ND has been
made the current options are for sentinel biopsy, selec-
tive or supraselective neck dissection, ipsilateral MRND
or bilateral MRND. Either diagnostic or therapeutic, the
role of neck dissection is highly dependent on the dis-
ease pattern and spread. To our knowledge this study is
the first to provide information on the pattern of lateral
invasion in N0 PTC using the new nomenclature [8].
Lateral OLNM were present in 18.6% of cases. There
is little data on lateral OLNM incidence. Ito found a
higher rate of 64% in 1321 patients with PTC [12]
whereas Wada reported an OLNM rate of 39.5% in the
lateral compartment of patients with microPTC [14].
Microcarcinoma analysis was excluded from our analy-
sis because the question of the extent of neck dissection
is of less interest in these cases. OLNM were confined
to only one level in 53% of cases, which is within the
range of various reports of 32% from Kupferman et al.,
39% from Pingpank et al. and 64% from Ducci et al.
[15-17] in therapeutic neck dissections. Lee et al. and
Sivanandan et al. reported a lower rate of 18% [18,19].
This wide range between studies may be explained by
the geographical variability, genetic changes in the
tumour tissue (ras-, gsp-,p53- and p21-mutations), accu-
racy in the clinical and imaging diagnosis of the N0
necks and variability of the extent of neck dissection
and pathological processes [20].
Levels III, IIa and IV were the most common levels
showing OLNM. This is consistent with findings in
other previously reported studies of therapeutic ND
[15,19] and with the conventional anatomy of lymphatic
drainage in the thyroid area. As found in this study,
level IIa and III are more likely to be invaded simulta-
neously [15,19,21] as a consequence of jugular lymphatic
vessels crossing these levels with direct drainage of the
upper thyroid.
In our study, the neck dissections were extended to
the level Ib in 70%, owing to the wide inclusion period.
Level Ib was excluded from lateral prophylactic neck
dissection along the period of inclusion as in many
other reports [13,15]. Level Ib involvement is only 3.1%
in this study, which is similar to the rate reported by
Roh et al [21]. The increasing reliability of US imaging
associated with the low OLNM risk in this level has led
us to avoid it in any ND for N0 neck PTC.
In our study, OLNM were found in level Vb (5.7%)
but were absent of level Va. Contrary to our results,
Roh et al. in a prospective study of 52 patients with
therapeutic ND found a higher percentage of LNM in
level Va than in Vb (13% vs. 3.7%) [21]. Unfortunately
no other study separates results from level Va and Vb.
For Kupferman et al. “anecdotal evidence suggests that
nodes inferior to the SAN (level Vb) along the trans-
verse cervical vessels harbour thyroid carcinoma metas-
tases whereas the nodes superior to the SAN are less
likely to be involved” [22]. The pattern of invasion from
inferior parts of the thyroid area toward the level Vb is
Figure 1 Percentage of metastases by level (numbers in
parentheses indicate number of ND specimens with OLNM/
total number of ND specimens).
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vessels in their transverse cervical drainage. Level Vb
was mostly associated to a level IV involvement which
has been reported by Kupferman et al. as the most sig-
nificant predictive factor of level V OLNM in PTC [22].
The isolated invasion of level Va and IIa are less under-
stood because these levels are not directly involved with
lymphatic drainage in physiological conditions. Level IIb
OLNM were observed in a few (2.9%) and only in cases
of invasion of the surrounding levels IIa and level III. In
therapeutic ND, Lee et al. found a low incidence of level
IIb LNM (6.8%) although a higher level of III LNM up
to 80% [18]. He concluded that level IIb ND should be
performed only if there is clinical or radiological evi-
dence of metastases at this level. In prophylactic neck
dissections where level III is less involved, level IIb dis-
section would lead to less likelihood of occult metas-
tases. In our study, no LNM occurred at level Va. These
latter observations were associated with a 65% reported
rate of shoulder pain and dysfunction after dissection of
the SAN [23,24] and are consistent with a strategy of
sparing these levels.
Of the population that underwent lateral and central
neck dissection, 8.1% had OLNM in the lateral com-
partment without any involvement of the central com-
partment. As found in our study, several lateral levels
may be involved simultaneously while the central com-
partment is spared [21]. Sivanandan et al. observed a
similar rate of 9.6% and lower rate for microcarcino-
mas (5.5%) [14,19]. These rates are too high to confirm
Machens theory that this is an epiphenomenon in PTC
23. Direct lymphatic drainage of part of the thyroid
gland toward levels II, III and IV partly explains this
phenomenon, however, it is likely that this rate is
highly dependent on the extent of the central compart-
ment dissection and also on the quality of histopatho-
logical procedure. Serial node sections and
immunohistochemistry would decrease the rate of iso-
lated lateral OLNM. In our strategy, the lateral com-
partment management is never based on the central
compartment status.
This retrospective study has several limitations. First,
this article does not address the issue of whether or not
to perform a prophylactic lateral neck dissection because
no comparative study of the impact of neck dissection
on recurrence, death and complications of surgery has
been performed. The aim of this study was to describe
the pattern and spread of occult lateral neck metastases
in PTC. Nevertheless, a major data of the present study,
the percentage of OLNM (18.6%), is arguing against
PLND. It is below the classical threshold of 20% of
occult metastases recommended by Weiss et al. to per-
form elective neck dissection in N0 head and neck squa-
mous cell carcinoma who are known to have more
aggressive neck metastases than PTC [25]. Second, this
study covers a long period of time (1974-2006), where
improvements in imaging may have resulted in differ-
ences in the likelihood of detecting preoperative LNM.
However, the vast majority of patients (92%) were diag-
nosed after 1985, at a time where ultrasound was used
routinely in our patients.
Conclusions
The present study provides more information on the
pattern of neck lymph node invasion in PTC in N0 dis-
ease. The findings suggest that OLNM occurs mainly in
level III, IIa, IV, and Vb. The incidence of OLNM after
prophylactic ND is much lower than after therapeutic
dissection. Invasion of levels Ib, IIb, and Va is a rare
event, but this increases when there are OLNM in other
surrounding areas. Although this study does not address
the issue of whether or not to perform a prophylactic
lateral neck dissection, it is of interest to surgeons who
usually perform PLND. In these cases we believe that
selective neck dissection of levels IIa, III, IV and Vb in
cases of PTC with N0 is sufficient for the clearance of
occult metastases.
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